Orchard Therapeutics plc
ORTXDelisted Jan 24, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001748907
Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Orchard Therapeutics plc changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 79 | 1 | 72 | −6 |
| Shares | 72.7M | 46.4K | 64.1M | −8.57M (−11.8%) |
| Value | $167.4M | $107.0K | $84.6M | −$82.7M (−49.4%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Orchard Therapeutics plc at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SG Americas Securities, LLC | 649,670 | $858.0K | 0.01% |
| Two Sigma Investments, LP | 542,212 | $716.0K | 0.00% |
| Anson Funds Management LP | 348,266 | $460.0K | 0.06% |
| Harbor Capital Advisors, Inc. | 275,870 | $364.0K | 0.13% |
| Two Sigma Advisers, LP | 189,700 | $250.0K | 0.00% |
| Acadian Asset Management LLC | 108,165 | $141.0K | 0.00% |
| Verition Fund Management LLC | 50,009 | $66.0K | 0.00% |
| Two Sigma Securities, LLC | 46,311 | $61.0K | 0.01% |
| Engineers Gate Manager LP | 30,326 | $40.0K | 0.00% |
| Ergoteles LLC | 23,172 | $31.0K | 0.00% |
| Golden State Equity Partners | 21,450 | $28.0K | 0.01% |
| Lane Generational LLC | 15,932 | $21.0K | 0.02% |
| PVG Asset Management Corp | 10,000 | $13.2K | 0.05% |
| Kestra Private Wealth Services, LLC | 10,033 | $13.0K | 0.00% |
| Steward Partners Investment Advisory, LLC | 1,000 | $1.00K | 0.00% |
| Aquatic Capital Management LLC | 400 | $1.00K | 0.00% |
| Brewin Dolphin Ltd | 1,000 | $1.00K | 0.00% |
| Beaird Harris Wealth Management, LLC | 120 | $0 | 0.00% |
Sold out (24)
Institutions that held Orchard Therapeutics plc at the end of Q3 2021 and filed for Q4 2021 without it.
Not filed for Q4 2021 yet (1)
Institutions that held Orchard Therapeutics plc at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 46,371 | $107.0K |